Irwin SL, et al. - The feasibility, tolerability, and patient acceptability of single-pulse transcranial magnetic stimulation (sTMS) for migraine prevention were assessed in adolescents in an open-label pilot study. Observations suggested that for migraine in adolescents, sTMS seemed to be a feasible, well-tolerated, and acceptable nonpharmacologic preventive treatment. No serious adverse events were identified.